Deputy of Genomic Technologies
In 2003, Dr. Pennacchio joined the DOE Joint Genome Institute and has focused on applying state-of-the-art molecular methods to address wide-ranging questions existing in biology. He holds joint appointments as a Deputy Director at the DOE Joint Genome Institute, Senior Scientist at Lawrence Berkeley Laboratory, and Adjunct Professor at UC Berkeley. Dr. Pennacchio received his Ph.D in 1998 from the Department of Genetics at Stanford University where he uncovered the genetic cause of a rare form of human epilepsy and subsequently generated one of the first mouse models for this common neurological disorder. In 1999, he was named a DOE Alexander Hollaender Distinguished Fellow where he identified a novel apolipoprotein (ApoA5) involved in human and mouse triglyceride metabolism. He is funded by DOE and through continued competitive grant support from NIH.
